spacer
spacer

PDBsum entry 2hdp

Go to PDB code: 
protein metals Protein-protein interface(s) links
Ligase PDB id
2hdp

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
63 a.a. *
Metals
_ZN ×4
* Residue conservation analysis
PDB id:
2hdp
Name: Ligase
Title: Solution structure of hdm2 ring finger domain
Structure: Ubiquitin-protein ligase e3 mdm2. Chain: a, b. Fragment: ring finger domain. Synonym: p53-binding protein mdm2. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: mdm2. Expressed in: escherichia coli. Expression_system_taxid: 562.
NMR struc: 20 models
Authors: M.Kostic,T.Matt,M.Yamout-Martinez,H.J.Dyson,P.E.Wright
Key ref:
M.Kostic et al. (2006). Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53. J Mol Biol, 363, 433-450. PubMed id: 16965791 DOI: 10.1016/j.jmb.2006.08.027
Date:
20-Jun-06     Release date:   21-Nov-06    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
Q00987  (MDM2_HUMAN) -  E3 ubiquitin-protein ligase Mdm2 from Homo sapiens
Seq:
Struc:
491 a.a.
63 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.2.3.2.27  - RING-type E3 ubiquitin transferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N6- ubiquitinyl-[acceptor protein]-L-lysine

 

 
DOI no: 10.1016/j.jmb.2006.08.027 J Mol Biol 363:433-450 (2006)
PubMed id: 16965791  
 
 
Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.
M.Kostic, T.Matt, M.A.Martinez-Yamout, H.J.Dyson, P.E.Wright.
 
  ABSTRACT  
 
Regulation of the transcriptional response to the tumor suppressor p53 occurs at many levels, including control of its transcriptional activity, and of its stability and concentration within the cell. p53 stability is regulated by the protein Hdm2, an E3 ubiquitin ligase that binds to p53 and promotes its ubiquitination and degradation. The C-terminal domain of Hdm2, which is critical for this activity, has been classified as a RING domain on the basis of sequence homology, although it lacks the canonical set of zinc ligands (RING domains typically have C3HC4 or C4C4 zinc coordination). Here, we report the solution structure of the C2H2C4 RING domain of Hdm2(429-491), which reveals a symmetrical dimer with a unique cross-brace zinc-binding scheme. Each subunit has one Cys4 Zn site and one His2Cys2 Zn site. The global fold of each subunit is similar to those reported for other RING domains, with a compact betabetaalphabeta fold, a small hydrophobic core, and two Zn ions, which are essential for maintaining the domain structure. The dimer structure is maintained by an extensive interface that buries a large hydrophobic area on each subunit. It has been proposed that Hdm2 and its homologue HdmX form a stable heterodimer through their RING domains, resulting in a synergistic increase in observed E3 activity. To test this proposal, we prepared an HdmX RING construct and showed by NMR titration that it forms a tight 1:1 complex with the Hdm2 RING. The resonances most perturbed by heterodimer formation are located within the subunit interface of the homodimer, far removed from the surface expected to form the docking site of the E2 ubiquitin-conjugating enzyme, providing a structure-based rationale for the function of the RING domains in p53 ubiquitination.
 
  Selected figure(s)  
 
Figure 6.
Figure 6. Solution structure of Hdm2(429–491) C2H2C4 RING domain. (a) Superposition of an ensemble of 20 lowest energy structures of the Hdm2(429–491) C2H2C4 RING homodimer, with the two subunits colored green and gold. The first eight and the last residue are not well-defined and are omitted for clarity. Zinc ions are shown as gray spheres. The Figure was prepared using PyMOL [http://www.pymol.sourceforge.net/]. (b) A ribbon representation of the lowest energy structure of a single subunit of Hdm2(429–491), showing the distribution of regular secondary structure elements and the location of two Zn^2+-binding sites. The side-chains of the zinc ligands are shown as balls, colored black (C), blue (N) or yellow (S). This Figure was prepared using MOLMOL.^78
Figure 10.
Figure 10. Structural overlay of the UbcH7/c-Cbl complex (PDB 1FBV)^55 with the UbcH5b structure (PDB 2ESK)^65 and the lowest-energy structure of the Hdm2(429–491) homodimer. This Figure was prepared using MOLMOL.^78
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2006, 363, 433-450) copyright 2006.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20671028 C.Priest, C.Prives, and M.V.Poyurovsky (2010).
Deconstructing nucleotide binding activity of the Mdm2 RING domain.
  Nucleic Acids Res, 38, 7587-7598.  
20689703 C.T.Chasapis, A.K.Loutsidou, M.G.Orkoula, and G.A.Spyroulias (2010).
Zinc Binding Properties of Engineered RING Finger Domain of Arkadia E3 Ubiquitin Ligase.
  Bioinorg Chem Appl, (), 0.  
19498444 J.C.Marine, and G.Lozano (2010).
Mdm2-mediated ubiquitylation: p53 and beyond.
  Cell Death Differ, 17, 93.  
20172729 M.Wade, Y.V.Wang, and G.M.Wahl (2010).
The p53 orchestra: Mdm2 and Mdmx set the tone.
  Trends Cell Biol, 20, 299-309.  
19373243 P.D.Mace, S.Shirley, and C.L.Day (2010).
Assembling the building blocks: structure and function of inhibitor of apoptosis proteins.
  Cell Death Differ, 17, 46-53.  
19776744 A.J.Levine, and M.Oren (2009).
The first 30 years of p53: growing ever more complex.
  Nat Rev Cancer, 9, 749-758.  
19188367 B.Wawrzynow, S.Pettersson, A.Zylicz, J.Bramham, E.Worrall, T.R.Hupp, and K.L.Ball (2009).
A function for the RING finger domain in the allosteric control of MDM2 conformation and activity.
  J Biol Chem, 284, 11517-11530.  
19483087 C.A.Corcoran, J.Montalbano, H.Sun, Q.He, Y.Huang, and M.S.Sheikh (2009).
Identification and characterization of two novel isoforms of Pirh2 ubiquitin ligase that negatively regulate p53 independent of RING finger domains.
  J Biol Chem, 284, 21955-21970.  
19568783 E.G.Worrall, B.Wawrzynow, L.Worrall, M.Walkinshaw, K.L.Ball, and T.R.Hupp (2009).
Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif.
  J Chem Biol, 2, 113-129.  
19721810 F.Mancini, G.D.Conza, and F.Moretti (2009).
MDM4 (MDMX) and its Transcript Variants.
  Curr Genomics, 10, 42-50.  
19147532 M.Wade, and G.M.Wahl (2009).
Targeting Mdm2 and Mdmx in cancer therapy: better living through medicinal chemistry?
  Mol Cancer Res, 7, 1.  
19465916 Q.Yin, S.C.Lin, B.Lamothe, M.Lu, Y.C.Lo, G.Hura, L.Zheng, R.L.Rich, A.D.Campos, D.G.Myszka, M.J.Lenardo, B.G.Darnay, and H.Wu (2009).
E2 interaction and dimerization in the crystal structure of TRAF6.
  Nat Struct Mol Biol, 16, 658-666.
PDB codes: 3hcs 3hct 3hcu
18567799 J.A.Barboza, T.Iwakuma, T.Terzian, A.K.El-Naggar, and G.Lozano (2008).
Mdm2 and Mdm4 loss regulates distinct p53 activities.
  Mol Cancer Res, 6, 947-954.  
19738896 J.A.Lehman, J.A.Eitel, C.N.Batuello, and L.D.Mayo (2008).
Therapeutic considerations for Mdm2: not just a one trick pony.
  Expert Opin Drug Discov, 3, 1309-1321.  
18219319 K.Linke, P.D.Mace, C.A.Smith, D.L.Vaux, J.Silke, and C.L.Day (2008).
Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.
  Cell Death Differ, 15, 841-848.
PDB codes: 2vje 2vjf
18809412 S.G.Sivakolundu, A.Nourse, S.Moshiach, B.Bothner, C.Ashley, J.Satumba, J.Lahti, and R.W.Kriwacki (2008).
Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo.
  J Mol Biol, 384, 240-254.  
17984062 C.Boularan, M.G.Scott, K.Bourougaa, M.Bellal, E.Esteve, A.Thuret, A.Benmerah, M.Tramier, M.Coppey-Moisan, C.Labbé-Jullié, R.Fåhraeus, and S.Marullo (2007).
beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53.
  Proc Natl Acad Sci U S A, 104, 18061-18066.  
17936560 K.Itahana, H.Mao, A.Jin, Y.Itahana, H.V.Clegg, M.S.Lindström, K.P.Bhat, V.L.Godfrey, G.I.Evan, and Y.Zhang (2007).
Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation.
  Cancer Cell, 12, 355-366.  
17170710 M.V.Poyurovsky, C.Priest, A.Kentsis, K.L.Borden, Z.Q.Pan, N.Pavletich, and C.Prives (2007).
The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity.
  EMBO J, 26, 90.  
17933515 P.Knipscheer, and T.K.Sixma (2007).
Protein-protein interactions regulate Ubl conjugation.
  Curr Opin Struct Biol, 17, 665-673.  
17301054 R.K.Singh, S.Iyappan, and M.Scheffner (2007).
Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
  J Biol Chem, 282, 10901-10907.  
17159902 S.Uldrijan, W.J.Pannekoek, and K.H.Vousden (2007).
An essential function of the extreme C-terminus of MDM2 can be provided by MDMX.
  EMBO J, 26, 102-112.  
17574027 X.Tang, S.Orlicky, Z.Lin, A.Willems, D.Neculai, D.Ceccarelli, F.Mercurio, B.H.Shilton, F.Sicheri, and M.Tyers (2007).
Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination.
  Cell, 129, 1165-1176.
PDB codes: 2p63 2p64
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer